WENTWORTH KORY JAMES

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
33
Insider Sells Sum
$1.5M

Insider Activity of WENTWORTH KORY JAMES

According to the SEC Form 4 filings, WENTWORTH KORY JAMES, being in a position of

  1. Chief Financial Officer at Entrada Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 21539 shares for $319,245,
    over all time since 2022-08-16, has bought 0 shares, and sold 84485 shares for $1.27M.

The largest sale of all time was on 2023-06-21 and amounted to 8907 shares of Entrada Therapeutics, Inc. for $135,129.

Biography of WENTWORTH KORY JAMES

No biography is available at this moment.

2024-09-09SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
3,195
0.0086%
$14.97$47,832-0.2%
2024-07-08SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
1,758
0.0055%
$14.95$26,2820%
2024-03-06SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
4,086
0.0123%
$12.31$50,285+18.48%
2023-12-26SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
94
0.0003%
$16.67$1,567-13.38%
2023-12-22SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
10,206
0.029%
$15.69$160,124-11.09%
2023-12-21SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
2,200
0.0068%
$15.07$33,155+0.27%
2023-09-06SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
950
0.0028%
$13.48$12,806+5.66%
2023-07-11SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
3,884
0.012%
$18.00$69,904-18.27%
2023-07-10SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
6,116
0.0189%
$17.98$109,958-18.13%
2023-06-21SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
8,907
0.0276%
$15.17$135,129-2.64%
2023-06-21SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
17,500
0.0536%
$15.01$262,648-2.64%
2023-03-02SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
1,747
0.0056%
$10.53$18,389+45.81%
2022-12-08SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
4,550
0.0131%
$18.95$86,238-29.95%
2022-12-05SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
200
0.0006%
$18.05$3,610-17.9%
2022-11-16SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
200
0.0007%
$18.10$3,620-14.91%
2022-08-25SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
1,551
0.0047%
$14.18$21,986+0.17%
2022-08-24SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
4,669
0.0144%
$13.78$64,362+3.28%
2022-08-23SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
2,909
0.0093%
$13.09$38,080+12.57%
2022-08-22SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
217
0.0007%
$13.00$2,822+12.5%
2022-08-19SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
8,746
0.0281%
$13.07$114,352+13.64%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.